The import of medicaments for therapeutic and prophylactic use in dosage to the Philippines is projected to grow from 1.6307 billion USD in 2024 to 1.8274 billion USD in 2028. Comparing these figures with the actual value in 2023, which stood at 1.5800 billion USD, we see steady year-on-year growth: a 3.2% increase from 2023 to 2024; a 3.1% increase from 2024 to 2025; a 3.0% increase from 2025 to 2026; a 2.8% increase from 2026 to 2027; and a 2.7% increase from 2027 to 2028. The compound annual growth rate (CAGR) over the five-year forecast period (2024-2028) averages at 2.96% annually.
Future trends to watch for include increased emphasis on preventive healthcare, technological advancements in medication, and the potential impact of global supply chain fluctuations on import values. Additionally, Philippines' expanding healthcare infrastructure and the population growth may drive higher demand for medicaments in the coming years.
